Markus Gstöttner, clock.bio CEO
October 8, 2024 07:00 AM EDT
Financing
Startups

Ex­clu­sive: Tiny start­up with big vi­sion to ex­tend healthspan by 20 years says it dis­cov­ered an ‘At­las of Re­ju­ve­na­tion’

Ryan Cross

Senior Science Correspondent

Last Au­gust, stem cell bi­ol­o­gist and bit.bio founder Mark Kot­ter launched a new start­up with an am­bi­tious goal: with­in a year, to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times